The CEAP classification is a standardized system that doctors use to describe and stage chronic venous disease of the legs. Developed in 1993 by an international consensus panel and updated several times since, it breaks venous disease into four domains: Clinical signs (C), Etiology (E), Anatomy (A), and Pathophysiology (P). The “C” classes, ranging from C0 (no visible signs) through C6 (active ulcer), are by far the most commonly used part of the system and the portion most patients encounter in their medical records. But the full framework does more than grade how a leg looks; it maps the underlying cause, the veins involved, and whether the problem is reflux, obstruction, or both.
What the Clinical Classes Actually Mean
The clinical component is the backbone of CEAP in everyday practice. It grades the visible and palpable signs of venous disease on a scale from C0 to C6, and each class has a specific definition:
- C0: No visible or palpable signs of venous disease.
- C1: Spider veins or reticular veins (small, web-like veins near the skin surface).
- C2: Varicose veins (dilated, tortuous veins at least 3 mm in diameter).
- C3: Edema (swelling) attributable to venous disease.
- C4: Skin changes caused by venous disease, including pigmentation, eczema, thickened skin, or scarring.
- C5: Healed venous ulcer.
- C6: Active venous ulcer.
Each class also carries a subscript: “s” for symptomatic (the patient reports aching, heaviness, itching, or other complaints) or “a” for asymptomatic. A person with visible varicose veins who feels fine might be classified C2a, while someone with the same veins plus daily leg pain would be C2s. This distinction matters because treatment decisions often hinge not just on what the doctor sees but on whether the patient is actually bothered by it.
What Changed in the 2020 Update
CEAP has gone through revisions in 1996, 2004, and most recently 2020. The core seven clinical classes stayed the same, but the 2020 update made several meaningful additions. Class C4 was split into three subclasses instead of two: C4a still covers pigmentation or eczema, C4b covers lipodermatosclerosis or atrophie blanche (a type of white scarring), and a new C4c was added for corona phlebectatica, a fan-shaped pattern of tiny veins around the ankle that signals worsening venous hypertension.1PubMed. What’s new in the 2020 update of the CEAP classification system of chronic venous disease? Corona phlebectatica had been recognized clinically for years but never had a formal place in the classification, so its addition was a practical acknowledgment of something vein specialists were already tracking.
The update also introduced an “r” modifier for recurrence. Varicose veins that come back after treatment are now designated C2r, and a recurrent active ulcer becomes C6r.2Journal of Vascular Surgery: Venous and Lymphatic Disorders. The 2020 update of the CEAP classification system and reporting standards – Section: Revisions to the clinical (C) classification Before this change, there was no formal way to distinguish a first-time varicose vein from one that had already been treated and returned, even though the treatment approach and expected outcomes differ considerably. The numeric codes for venous segments were also replaced with commonly used abbreviations, making the anatomical shorthand easier to remember and less prone to errors in documentation.
Beyond the C Classes
Most patients only hear about the C class, but the other three letters carry information that shapes treatment planning. The etiology domain (E) records why the venous disease developed. Four categories exist: congenital (Ec), meaning the person was born with a venous abnormality such as absent valves or a vascular malformation; primary (Ep), meaning the disease arose on its own without an obvious preceding event; secondary (Es), meaning something caused the damage; and no identifiable venous cause (En).3Journal of Vascular Surgery. Revision of the CEAP classification for chronic venous disorders: Consensus statement – Section: Revision of CEAP: Summary
The secondary category got more detailed in 2020. It is now split into intravenous causes (Esi) and extravenous causes (Ese). Intravenous means something damaged the vein wall or valves from the inside, the most common example being a prior deep vein thrombosis. Extravenous means the veins themselves are structurally intact but something outside them is interfering with blood flow, such as obesity raising abdominal pressure, a pelvic mass compressing a vein, or severe immobility impairing the calf muscle pump.4Journal of Vascular Surgery: Venous and Lymphatic Disorders. The 2020 update of the CEAP classification system and reporting standards – Section: Revisions to the etiologic (E) classification This matters because the treatment for a vein damaged by clot is quite different from treatment for a vein compressed by external tissue.
The anatomy domain (A) identifies which veins are involved: superficial veins (As), deep veins (Ad), perforating veins (Ap, the connectors between superficial and deep), or no identifiable venous location (An). The pathophysiology domain (P) records what the blood is doing wrong: reflux (Pr, meaning blood flows backward through leaky valves), obstruction (Po, meaning something is blocking forward flow), both reflux and obstruction (Pr,o), or no identifiable pathophysiology (Pn).5Journal of Vascular Surgery. Revision of the CEAP classification for chronic venous disorders: Consensus statement – Section: Revision of CEAP: Summary
How Duplex Ultrasound Fits In
You can assign a C class just by looking at and examining the leg, but filling in the A and P domains requires imaging. Duplex ultrasound is the standard tool for this, combining a picture of the vein structure with color-coded blood flow measurements that show whether blood is moving in the right direction and whether any segments are blocked. This is where vein specialists confirm whether the problem is reflux, obstruction, or both, and pinpoint which veins are affected.6Bangladesh Journal of Radiology and Imaging. Duplex Ultrasound Evaluation of Chronic Venous Disease According to CEAP Classification: A Prospective Hemodynamic Study
One study that mapped ultrasound findings against CEAP classes found that reflux was present in about 77% of patients. Superficial vein reflux was the most common pattern, appearing in over half the patients studied, while deep vein reflux and perforator reflux were less frequent. Obstruction was found in roughly a third of patients, and about one in five had both reflux and obstruction together. The combination of deep reflux and obstruction was especially common in patients with venous ulcers, confirming that the worst clinical outcomes tend to involve multiple problem areas rather than a single failing valve.7PubMed. Chronic venous disease: Correlation between ultrasound findings and the clinical, etiologic, anatomic and pathophysiologic classification
How Reliable Is the Classification?
Any classification system is only useful if different clinicians arrive at the same answer when they look at the same leg. A recent reproducibility study found that CEAP clinical class assignments agreed 76% of the time when the same examiner re-evaluated the same patient, and 63% of the time between different examiners. The weakest agreement was at the lower end of the scale, between C0, C1, and C2. Distinguishing a leg with no signs at all from one with faint spider veins, or spider veins from borderline varicose veins, involves a degree of judgment that introduces variability. When standardized examination protocols were followed, agreement improved substantially.8PubMed. Reproducibility of ultrasound and CEAP classification to describe possible chronic venous disorders in the legs
The higher C classes, particularly C4 through C6, are easier to agree on because the signs are more obvious. Skin discoloration, scarring, and ulceration are hard to miss or misinterpret. This means the classification is more consistent for the patients who need it most, those with advanced disease requiring active treatment, and somewhat fuzzier in the early stages where the clinical implications are less urgent anyway.
CEAP and Symptom Severity Scores
One common point of confusion is that CEAP describes what the disease looks like and where it comes from, but it was never designed to measure how bad the patient feels or to track change over time. For that, clinicians use a separate tool called the Venous Clinical Severity Score (VCSS), which grades individual symptoms like pain, varicose veins, edema, and skin changes on a numerical scale. The VCSS can be measured before and after treatment to see whether a procedure helped.9PubMed. Use of the Clinical, Etiologic, Anatomic, and Pathophysiologic classification and Venous Clinical Severity Score to establish a treatment plan for chronic venous disorders
In practice, doctors tend to use both together. CEAP tells you the type of disease and where it sits anatomically, while the VCSS gives you a number that can go up or down as the patient improves or worsens. Pairing them with a patient-reported quality-of-life questionnaire rounds out the picture, since what bothers one person with C3 swelling may barely register for another.
Quality of Life Across the C Classes
Multiple studies have looked at how quality of life declines as CEAP class increases, and the pattern is consistent: every step up the C-class ladder is associated with worse physical functioning, more pain, and greater psychological burden. One large study found that quality of life was affected to at least a mild or moderate degree in most patients with chronic venous disease, and that the impact worsened progressively from C0 through C6 across physical, psychological, and social dimensions.10PubMed Central. Impact of chronic venous disease on quality of life: Results of vein alarm study Another study confirmed this progressive decline after adjusting for age, body mass index, and number of symptoms, meaning the CEAP class itself independently predicted lower quality of life rather than just being a proxy for getting older or heavier.11Journal of Vascular Surgery. Quality of life in chronic venous disease patients measured by short Chronic Venous Disease Quality of Life Questionnaire (CIVIQ–14) in Serbia
After varicose vein surgery, patients classified as C2 or C3 before the procedure reported significantly better quality-of-life outcomes at twelve months compared with those starting at C4 through C6. Older age, higher anxiety levels, and higher VCSS scores at baseline also predicted poorer recovery, suggesting that early intervention when the disease is still at a lower class may yield better long-term results.12PubMed Central. Quality-of-life outcomes after varicose vein surgery: A 12-month prospective study of 605 patients identifying key prognostic factors
How Venous Disease Progresses Through the Classes
CEAP provides a snapshot, not a movie. It captures the state of the veins at a single point in time. But long-term follow-up data show that venous disease does tend to progress to higher classes over the years. In the Edinburgh Vein Study, which followed over 300 patients for a mean of about 13 years, roughly 58% had progressed to more severe disease or developed new varicose veins, with an annual progression rate of about 5%. Almost a third of patients who started with varicose veins went on to develop skin changes, putting them at risk for ulceration.13PubMed Central. How Does Chronic Venous Disease Progress from the First Symptoms to the Advanced Stages? A Review
The factors that predict faster progression are familiar: older age, higher body mass index, family history of varicose veins, prior deep vein thrombosis, and the presence of reflux in multiple vein segments. In particular, reflux in the small saphenous vein combined with deep vein reflux was strongly associated with moving to a higher C class. Risk factors identified in the Edinburgh data included age over 55, obesity, female sex, and superficial reflux, all of which roughly doubled or tripled the odds of progression.14Annals of Phlebology. Chronic Venous Disease is a Progressive Disease that Requires Early Intervention
Disease that begins after a deep vein thrombosis (secondary etiology) tends to progress faster than disease that arises on its own (primary etiology). When both reflux and obstruction are present, or when a patient has had a recurrent clot in the same leg, the chances of advancing to skin changes or ulceration rise sharply. For people whose veins were normal at baseline, developing venous disease was relatively uncommon and slow, reinforcing the idea that the condition tends to snowball once it gets a foothold.15PubMed. Secondary chronic venous disease progresses faster than primary
Post-Thrombotic Syndrome and the CEAP Framework
Post-thrombotic syndrome (PTS) is the chronic aftermath of a deep vein thrombosis: the clot damages the vein valves, blood pools, and the leg develops pain, swelling, and eventually skin changes or ulcers. CEAP is one of several tools used to evaluate and classify PTS, alongside dedicated scoring systems like the Villalta scale. While the Villalta scale was designed specifically for PTS and scores individual symptoms, CEAP provides the broader descriptive framework, especially the etiology and pathophysiology domains, which capture the thrombotic origin of the problem.16PubMed. Definition of the post-thrombotic syndrome, differences between existing classifications
Obesity has been highlighted as particularly relevant in this context. Research has pointed to a strong correlation between higher body mass index and more advanced CEAP clinical class, likely because increased abdominal pressure drives more reflux, larger vein diameters, and higher venous pressures in the legs.17PubMed Central. Post‐Thrombotic Syndrome: Pathophysiology, Clinical Implications, and Advances in Management For patients who have had a DVT, weight management is not just general health advice; it directly affects where they end up on the CEAP scale.
How Common Each C Class Is Worldwide
A systematic review pooling data from 32 studies across six continents found that the most prevalent clinical class globally was C1 (spider veins), affecting roughly a quarter of the population studied. About one in five people had C2 varicose veins, while C3 edema appeared in about 8%. Skin changes (C4) were present in around 4% of people, healed ulcers (C5) in about 1%, and active ulcers (C6) in under half a percent. The prevalence of varicose veins was highest in Western Europe and lowest in the Middle East and Africa, though the review noted substantial variation between studies.18Annals of Surgery. Global Epidemiology of Chronic Venous Disease: A Systematic Review With Pooled Prevalence Analysis
Commonly reported risk factors included female sex, which carried about a twofold increased odds, along with increasing age, obesity, prolonged standing occupations, family history, and having had pregnancies. Caucasian ethnicity was also identified as a risk factor, though whether this reflects true biological susceptibility or differences in healthcare access, diagnostic rates, and study recruitment is hard to disentangle from the available data.
What Happens Under the Skin
The underlying mechanism that drives progression through the C classes starts with sustained high pressure in the leg veins. When valves fail and blood pools, the pressure is transmitted to the smallest vessels in the skin. This leads to fluid leaking out of capillaries and causing edema (the hallmark of C3). An inflammatory cascade follows: white blood cells become activated, stick to the capillary walls, and increase the permeability of the tiny blood vessels even further.19PubMed Central. The microvascular pathophysiology of chronic venous insufficiency Over time, this chronic inflammation deposits pigment, thickens the skin, and eventually breaks it down into an ulcer. The C classes essentially map onto this progression: C3 reflects the fluid phase, C4 reflects the inflammatory skin damage phase, and C5/C6 reflect the tissue breakdown phase.
When the Problem Starts in the Pelvis
CEAP was built to classify venous disease in the legs, but some leg symptoms actually originate from pelvic veins. Conditions like pelvic venous congestion can cause varicose veins in the thighs, vulvar area, or buttocks that look like typical leg venous disease on the surface. A separate classification called SVP (Symptoms-Varices-Pathophysiology) was developed specifically for pelvic venous disorders, and experts recommend using it alongside CEAP rather than trying to force pelvic-origin problems into a leg-only framework.20PubMed. The Symptoms-Varices-Pathophysiology classification of pelvic venous disorders If you have varicose veins that recur after treatment or appear in unusual locations like the inner thigh, a pelvic venous evaluation may be warranted alongside the standard leg-focused workup.
Artificial Intelligence and Automated Staging
One emerging development is the use of AI to automate the early C classes. A model called IVENUS was recently trained to classify lower limb photographs into C0, C1, or C2 using deep learning. In external validation on over 1,600 photographs, the model achieved about 85% diagnostic accuracy and roughly 92% specificity, meaning it was quite good at correctly ruling out a class a patient did not have.21PubMed Central. Development and validation of the IVENUS artificial intelligence model for automated CEAP classification of early-stage chronic venous disease using lower limb photographs This is still a research tool, not a replacement for a clinical exam, and it only handles the early classes where human agreement is already weakest. But it hints at a future where smartphone-based screening could flag people who should see a vein specialist before their disease progresses beyond the point where outcomes are best.
The timing is relevant because, as the reproducibility data showed, the C0-to-C2 range is exactly where clinicians disagree the most. If an automated system could triage these borderline cases more consistently, it could help identify early disease that might otherwise go unrecognized until skin changes or ulcers develop. Whether that translates into meaningfully earlier treatment and better long-term results is a question that will take years of follow-up to answer.